Current available therapies and future directions in the treatment of malignant gliomas | Zendy

James J. Vredenburgh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current available therapies and future directions in the treatment of malignant gliomas

Author(s) -

James J. Vredenburgh

Publication year - 2008

Publication title -

biologics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.948

H-Index - 38

eISSN - 1177-5491

pISSN - 1177-5475

DOI - 10.2147/btt.s3098

Subject(s) - medicine , glioma , disease , oncology , bioinformatics , cancer research , biology

The prognosis of patients diagnosed with malignant glioma (MG) remains poor. However, recent advances in neuro-oncology allowing a better understanding of this particular disease have allowed the development of new therapeutics. Many molecular genetic and signal transduction pathway targets have been identified that are now being investigated. Novel locoregional treatments, as well as strategies to improve regional delivery, are being evaluated. Studies of combinations of these approaches are also underway. In this review, we will discuss the current and future therapies under evaluation for the treatment of malignant gliomas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research